Search for: "Lee v. Doe et al"
Results 41 - 60
of 323
Sorted by Relevance
|
Sort by Date
3 Jun 2016, 6:40 am
Lee, No. 15-446 (BRI construction in IPRs; institution decisions unreviewable) Argued: Stryker Corporation, et al. v. [read post]
9 Jul 2015, 10:03 am
Blackhorse, et. al., No. 1:14-cv-01043-GBL-IDD (E.D. [read post]
13 Oct 2014, 2:03 pm
Thus, for instance, Epstein et al. [read post]
16 Nov 2007, 1:08 am
REES, ET AL., Respondents. [read post]
21 Apr 2016, 3:22 pm
Amanda Blackhorse, et al., 112 F. [read post]
21 Apr 2016, 3:22 pm
Amanda Blackhorse, et al., 112 F. [read post]
9 Oct 2012, 3:00 am
” The 3rd Circuit court in Lee v. [read post]
5 Sep 2016, 6:46 pm
Post Grant Admin: Merck & Cie, et al. v. [read post]
4 Oct 2006, 6:26 am
Merrill et al. eds., 2004) . . .Seeking to support their assertions about Federal Circuit caselaw, these few commentators have quoted isolated statements from three of our precedents [In re Dembiczak, In re Lee, and Ruiz v. [read post]
18 Dec 2006, 1:29 pm
Melissa Ragsdale (NFP) Manuel Lee Gomez, et al. v. [read post]
8 May 2008, 12:01 pm
Ohio County, Indiana, et al (NFP) In the Matter of R.W. and M.W. [read post]
16 Jan 2017, 5:44 pm
Ltd. et al. v. [read post]
2 Jun 2017, 3:00 am
_St_Bernard’s_Hospital_Inc.. et al., 2017 WL 1405034 (8th Cir. [read post]
12 Mar 2014, 7:14 am
Spansion, Inc. et al., 3-13-cv-00679 (VAED March 10, 2014, Order) (Payne, J.) [read post]
26 Oct 2011, 1:14 pm
Earlier this month down in San Antonio federal court, #1 Fan Company and Spirit Industries commenced the ultimate case of finger-pointing in their copyright infringement complaint in #1 Fan Company et al. v Pangea Direct. [read post]
3 May 2016, 1:42 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 Jun 2019, 10:35 am
See, e.g., Jerry Kang, et al., Implicit Bias in the Courtroom, Jerry Kang et al., 9 UCLA L. [read post]
1 Oct 2010, 5:18 pm
[et al.] [read post]
1 Apr 2016, 8:22 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 May 2016, 8:19 am
Lee, No. 15-446 (BRI construction in IPRs; institution decisions unreviewable) Argued: Stryker Corporation, et al. v. [read post]
